Lou B Lou
Senior Member (Voting Rights)
Post copied from this thread about another app developed by ELAROS:
The ELAROS NHS digital system for patient/clinician digital sharing questionnaire data, includes Yorkshire Rehab. Scale and Open-OH app
'Mi-Trial launches innovative new clinical trials app and portal to improve trial participation and outcomes'
Professor Paul O’Brien, Elaros CEO, said:
“ELAROS is delighted to be part of this exciting new venture where we can bring our extensive experience of developing clinical and research platforms and patient-facing apps into the clinical trial space. ELAROS’s recent relevant experience has been in developing and launching a Long COVID clinical and research platform, with a patient facing app which is now being used by 35 NHS trusts. These experiences and expertise will be brought into Mi-Trial Limited and will support the deep clinical trial experience that the other two partners bring to this new venture.”
The Mi-Trial system is available on iOS, Android and as a web-based app. To find out more about Mi-Trial, visit www.mi-trial.com.
'Mi-Trial, a new company which has developed an innovative clinical trial companion system and app, has recently spun out from the University of Manchester with support from Elaros 24/7 Limited, Medicines Evaluation Unit Limited and the University of Manchester Innovation Factory.
Founded by Professor Alex Horsley and Professor Jacky Smith, Mi-Trial’s clinical trial companion system and app have been designed to meet the needs of both trial participants and those managing trials while reinforcing the trial’s integrity.
In addition to the patient-facing app, which securely replaces the multiple pieces of paper traditionally used by trial participant and also provides reminders and updates, Mi-Trial utilises a portal to manage trial scheduling. The portal allows flexible scheduling of study protocols and avoids scheduling errors while reducing deviations. Perhaps most conveniently, the portal allows a robust communication channel between the parties involved in the trial.
Developed by experts in trials design and delivery as well as innovators in software design and usability, Mi-Trial will streamline the trial process, reducing visit errors and data wastage while saving time and costs for both trial centres and sponsors.'
https://meu.org.uk/mi-trial-launches-new-clinical-trials-app/
.
The ELAROS NHS digital system for patient/clinician digital sharing questionnaire data, includes Yorkshire Rehab. Scale and Open-OH app
'Mi-Trial launches innovative new clinical trials app and portal to improve trial participation and outcomes'
Professor Paul O’Brien, Elaros CEO, said:
“ELAROS is delighted to be part of this exciting new venture where we can bring our extensive experience of developing clinical and research platforms and patient-facing apps into the clinical trial space. ELAROS’s recent relevant experience has been in developing and launching a Long COVID clinical and research platform, with a patient facing app which is now being used by 35 NHS trusts. These experiences and expertise will be brought into Mi-Trial Limited and will support the deep clinical trial experience that the other two partners bring to this new venture.”
The Mi-Trial system is available on iOS, Android and as a web-based app. To find out more about Mi-Trial, visit www.mi-trial.com.
'Mi-Trial, a new company which has developed an innovative clinical trial companion system and app, has recently spun out from the University of Manchester with support from Elaros 24/7 Limited, Medicines Evaluation Unit Limited and the University of Manchester Innovation Factory.
Founded by Professor Alex Horsley and Professor Jacky Smith, Mi-Trial’s clinical trial companion system and app have been designed to meet the needs of both trial participants and those managing trials while reinforcing the trial’s integrity.
In addition to the patient-facing app, which securely replaces the multiple pieces of paper traditionally used by trial participant and also provides reminders and updates, Mi-Trial utilises a portal to manage trial scheduling. The portal allows flexible scheduling of study protocols and avoids scheduling errors while reducing deviations. Perhaps most conveniently, the portal allows a robust communication channel between the parties involved in the trial.
Developed by experts in trials design and delivery as well as innovators in software design and usability, Mi-Trial will streamline the trial process, reducing visit errors and data wastage while saving time and costs for both trial centres and sponsors.'
https://meu.org.uk/mi-trial-launches-new-clinical-trials-app/
.
Last edited by a moderator: